Literature DB >> 7543674

Angiogenesis and the placental environment.

T Wheeler1, C L Elcock, F W Anthony.   

Abstract

Rapid growth and vascularization of the human placenta are characteristic of early pregnancy and are accomplished in an unusually hypoxic environment. Stimulation of placental growth through hypoxia-induced angiogenesis may therefore be of particular importance. We have previously found that several varieties of vascular endothelial growth factor (VEGF) mRNA, including VEGF165, are present in cultured placental fibroblasts. We hypothesized that hypoxia would increase the transcription and translation of VEGF by these cells and provide one mechanism linking placental development with its environment. Placental fibroblasts were grown in aerobic or anaerobic atmospheric conditions for 72 h. By 24 h the oxygen tension of the anaerobic culture media was significantly less than that of the aerobic cultures. RNA was extracted from the cells at 24, 48 and 72 h. Following reverse transcription polymerase chain reaction (RT-PCR) stronger signals for VEGF were always found in the anaerobic cultures and this was confirmed by competitive PCR. mRNA for VEGF165 was represented most strongly but the anaerobic cultures also showed clearly mRNA for VEGF121, VEGF189 and VEGF206. The VEGF protein was also measured in the aerobic and anaerobic culture medium. By 72 h the average concentration of VEGF was significantly higher (P = 0.01) in the anaerobic culture medium. VEGF production is one mechanism through which oxygen supply may influence placental development. Examples of this may include the compensatory placental hypertrophy associated with maternal anaemia and with reproduction at high altitude.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543674     DOI: 10.1016/0143-4004(95)90115-9

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  13 in total

Review 1.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

Review 2.  Aging of the placenta.

Authors:  H Fox
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

Review 3.  Preeclampsia: What Does the Father Have to Do with It?

Authors:  V Katsi; I Felekos; C Siristatidis; S Kasioni; A Drakontaidis; G Farmakides; T Makris; C Aggeli; P Nihoyannopoulos; D Tousoulis; I Kallikazaros
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

4.  Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy.

Authors:  Stacy Zamudio; Marcus Borges; Lourdes Echalar; Olga Kovalenko; Enrique Vargas; Tatiana Torricos; Abdulla Al Khan; Manuel Alvarez; Nicholas P Illsley
Journal:  Biol Reprod       Date:  2014-02-27       Impact factor: 4.285

5.  Expression of vascular endothelial growth factor (VEGF) under hypoxia in placenta with intrahepatic cholestasis of pregnancy and its clinically pathological significance.

Authors:  Rong Zhang; Xiao-Hong Pan; Li Xiao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 6.  An unexpected tail of VEGF and PlGF in pre-eclampsia.

Authors:  David O Bates
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

Review 7.  Perspectives of SLIT/ROBO signaling in placental angiogenesis.

Authors:  Wu-xiang Liao; Deborah A Wing; Jian-Guo Geng; Dong-bao Chen
Journal:  Histol Histopathol       Date:  2010-09       Impact factor: 2.303

Review 8.  Secretory products of the corpus luteum and preeclampsia.

Authors:  María M Pereira; Monica Mainigi; Jerome F Strauss
Journal:  Hum Reprod Update       Date:  2021-06-22       Impact factor: 15.610

Review 9.  Placental adaptations in growth restriction.

Authors:  Song Zhang; Timothy R H Regnault; Paige L Barker; Kimberley J Botting; Isabella C McMillen; Christine M McMillan; Claire T Roberts; Janna L Morrison
Journal:  Nutrients       Date:  2015-01-08       Impact factor: 5.717

10.  In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.

Authors:  Gabor Szalai; Yi Xu; Roberto Romero; Tinnakorn Chaiworapongsa; Zhonghui Xu; Po Jen Chiang; Hyunyoung Ahn; Birgitta Sundell; Olesya Plazyo; Yang Jiang; Mary Olive; Bing Wang; Suzanne M Jacques; Faisal Qureshi; Adi L Tarca; Offer Erez; Zhong Dong; Zoltan Papp; Sonia S Hassan; Edgar Hernandez-Andrade; Nandor Gabor Than
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.